Efficacy and Safety of RC28-E Versus Aflibercept in Diabetic Macular Edema

Clinical trial NCT05885503 · UNKNOWN

Trial details

NCT number: NCT05885503
Sponsor: RemeGen Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2023-06-08
Primary completion: 2026-06-01
Enrollment: 316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.